Notifications
12 minutes, 25 seconds
-34 Views 0 Comments 0 Likes 0 Reviews
The global vascular stents market has witnessed significant growth, with the market size reaching a value of nearly USD 10.57 billion in 2023. The vascular stents industry is poised for continued expansion, projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, ultimately reaching an estimated value of USD 17.10 billion by 2032. This growth trajectory reflects the increasing prevalence of cardiovascular diseases, advancements in stent technologies, and the growing global healthcare infrastructure.
Vascular stents are medical devices used to treat narrow or weakened arteries, ensuring blood flow through constricted vessels. These devices play a critical role in treating a variety of cardiovascular conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. The market for vascular stents is highly dynamic, influenced by technological advancements, regulatory factors, and a rising patient population. This blog post explores the various aspects of the vascular stents market, from its segments and trends to the key players and COVID-19's impact on the industry.
The vascular stents market is highly competitive, with several leading players dominating the industry. These companies offer a range of products, including bare-metal stents (BMS), drug-eluting stents (DES), bioresorbable stents, and other innovations. Some of the key players in the vascular stents market include:
Medtronic PLC
Based in Dublin, Ireland, Medtronic is one of the world's largest medical device companies. Medtronic’s portfolio includes both coronary and peripheral vascular stents, with products like the Resolute Onyx Drug-Eluting Stent and Hercules Balloon-Expandable Stent. The company is also actively involved in the development of bioresorbable stents.
Abbott Laboratories
Abbott, a global healthcare company headquartered in Illinois, USA, is known for its advanced vascular stent offerings. Abbott’s Xience Sierra Drug-Eluting Stent and Absorb Bioresorbable Vascular Scaffold are among the market leaders in coronary artery disease treatment.
Boston Scientific Corporation
With its headquarters in Marlborough, Massachusetts, USA, Boston Scientific offers a variety of stents, including the Promus Element Plus and Synergy Stent. The company also focuses on developing innovative solutions, such as bioresorbable stents and drug-eluting stent technologies.
Johnson & Johnson
Through its subsidiary, Cordis, Johnson & Johnson is a key player in the vascular stent market. The Cypher Stent and the Cobalt Stent are some of the notable products in its coronary stent portfolio.
Terumo Corporation
Based in Tokyo, Japan, Terumo offers vascular stents under its Terumo Stent and Ultrathin Stent lines. The company is committed to advancing minimally invasive medical technologies for vascular interventions.
B. Braun Melsungen AG
A leading German medical device company, B. Braun offers various products, including vascular stents used in the treatment of coronary artery diseases. B. Braun’s Avitene and Eclats Stent are well-regarded within the market.
These companies are continually innovating to improve the efficacy and safety of stents, investing in research and development to cater to the evolving needs of the healthcare sector.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample
The vascular stents market can be segmented by product type, application, end-user, and region. Understanding these segments helps stakeholders in the industry make informed decisions based on specific market dynamics.
The vascular stents market is primarily divided into the following types:
The vascular stents market is segmented based on application, primarily:
The vascular stents market is segmented by end-users, which include:
Hospitals dominate this segment due to the high volume of vascular interventions performed in these settings.
The vascular stents market is segmented into regions, which include:
The vascular stents market is expected to continue its upward trajectory in the coming years, driven by several key factors:
Rising Cardiovascular Diseases: Cardiovascular diseases (CVDs) are a leading cause of death globally. With the increasing prevalence of lifestyle-related risk factors such as hypertension, obesity, and smoking, the demand for stents is expected to rise steadily.
Technological Advancements: Continuous innovation in stent technology, such as drug-eluting stents, bioresorbable stents, and improvements in materials, is enhancing the effectiveness and safety of vascular interventions.
Increasing Geriatric Population: The global ageing population, particularly in developed regions, is contributing to an increased incidence of age-related cardiovascular conditions, which, in turn, boosts the demand for vascular stents.
Minimally Invasive Procedures: The growing preference for minimally invasive surgeries, which involve fewer complications and shorter recovery times, is boosting the adoption of vascular stents.
Several trends are shaping the future of the vascular stents market, including:
Rise in Minimally Invasive Procedures: There is an increasing preference for minimally invasive surgeries due to their associated benefits, including shorter hospital stays, reduced risk of infection, and quicker recovery times. This trend is driving the demand for vascular stents, which are integral to these procedures.
Innovation in Drug-Eluting Stents: Drug-eluting stents (DES) have revolutionized the treatment of coronary artery disease. Manufacturers are focusing on further improving these stents by developing new drugs with fewer side effects and improved long-term outcomes.
Bioresorbable Stents: Bioabsorbable or bioresorbable stents, which dissolve over time, are becoming an area of active research and development. These stents are expected to reduce the long-term complications associated with traditional metallic stents.
3D-Printed Stents: With advancements in 3D printing technology, custom-made stents tailored to the unique anatomy of patients are becoming a possibility. This is particularly useful in complex cases where standard stents might not be effective.
The COVID-19 pandemic had a significant impact on the vascular stents market. During the height of the pandemic, elective surgeries were postponed, and the healthcare system focused on managing COVID-19 cases. This resulted in a temporary decline in the number of stent procedures performed. However, with the gradual reopening of healthcare services and the increasing emphasis on cardiovascular care, the market has begun to recover.
Moreover, the pandemic has highlighted the need for improving cardiovascular healthcare infrastructure, especially in developing regions, further driving the demand for vascular stents in the long term.
What are vascular stents?
Vascular stents are small mesh-like devices used to treat narrowed or blocked arteries. They help maintain blood flow in affected vessels and are commonly used in coronary artery disease, peripheral artery disease, and carotid artery disease.
What is the difference between bare-metal stents and drug-eluting stents?
Bare-metal stents (BMS) are made from metal and are the traditional form of stent. Drug-eluting stents (DES) are coated with medication that helps prevent the re-narrowing of arteries by inhibiting the growth of scar tissue.
How do bioresorbable stents work?
Bioresorbable stents are designed to dissolve after they have supported the artery long enough to restore blood flow. They are being developed as an alternative to traditional metal stents, potentially reducing the risk of long-term complications.
What is the expected growth rate of the vascular stents market?
The vascular stents market is expected to grow at a CAGR of 5.5% from 2024 to 2032, reaching a value of nearly USD 17.10 billion by 2032.
Which region leads the vascular stents market?
North America currently leads the vascular stents market due to advanced healthcare infrastructure, high adoption of medical technologies, and a large patient base.
How has COVID-19 impacted the vascular stents market?
The COVID-19 pandemic temporarily slowed the growth of the vascular stents market, with delays in elective surgeries. However, the market is recovering as healthcare services resume, and the demand for cardiovascular care increases.
Global Vascular Stents Market Global Vascular Stents Market Trends
